POINT Biopharma Global Inc.
POINT Biopharma Global Inc. (PNT) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 46 transactions totaling $218.3M, demonstrating a bearish sentiment with -$217.4M in net insider flow. The most recent transaction on Dec 27, 2023 involved a transaction of 1,710 shares valued at $0.
PNT Insider Activity Summary
Who Is Buying PNT Stock?
No significant insider buying has been recorded for PNT in the recent period.
Who Is Selling PNT Stock?
No significant insider selling has been recorded for PNT in the recent period.
Is POINT Biopharma Global Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PNT is bearish with an Insider Alignment Score of 0/100 and a net flow of -$217.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PNT Frequently Asked Questions
Understanding PNT Insider Activity
Insider trading at POINT Biopharma Global Inc. (PNT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading PNT stock, having executed 46 transactions in the past 90 days. The most active insider is Inc/il Bvf (Executive), who has made 3 transactions totaling $213.7M.
Related Tools
Track POINT Biopharma Global Inc. Insider Activity
Get notified when executives and directors at PNT file new Form 4 transactions